Article Details
Retrieved on: 2025-02-15 21:10:47
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses advancements in healing renal cell carcinoma using Cabozantinib, Nivolumab, and Ipilimumab. These orphan antineoplastic drugs improve progression-free survival but not overall survival, impacting cancer treatment strategies.
Article found on: www.curetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here